Q2 2023 Holdings
Filed 2023-08-11 | 30 holdings | $625.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $73.3M | 3,082,622 | 11.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $55.5M | 4,684,132 | 8.9% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $54.2M | 3,000,000 | 8.7% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $45.5M | 2,230,127 | 7.3% |
| Merus N V | COM | N5749R100 | $45.5M | 1,726,214 | 7.3% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $41.7M | 3,517,125 | 6.7% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $40.9M | 2,484,960 | 6.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $26.3M | 2,916,667 | 4.2% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $26.0M | 2,972,869 | 4.2% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $25.5M | 1,973,251 | 4.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $24.5M | 2,173,913 | 3.9% |
| Celcuity Inc(CELC) | COM | 15102K100 | $23.1M | 2,105,386 | 3.7% |
| Savara Inc(SVRA) | COM | 805111101 | $20.3M | 6,351,531 | 3.2% |
| Pharvaris N V(PHVS) | COM | N69605108 | $20.1M | 1,326,200 | 3.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $18.0M | 1,090,000 | 2.9% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $16.6M | 2,142,856 | 2.7% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $10.8M | 1,040,754 | 1.7% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $8.2M | 3,422,397 | 1.3% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $7.2M | 5,658,034 | 1.2% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $7.2M | 770,000 | 1.1% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $6.3M | 2,208,812 | 1.0% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $6.2M | 3,886,246 | 1.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $6.1M | 5,304,410 | 1.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $5.2M | 288,949 | 0.8% |
| Lyra Therapeutics Inc(LYRA) | COM | 55234L105 | $3.8M | 924,170 | 0.6% |
| Aeglea Biotherapeutics Inc(AGLEUSD) | COM | 00773J103 | $2.9M | 6,343,221 | 0.5% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $1.8M | 353,629 | 0.3% |
| Rallybio Corp | COM | 75120L100 | $1.5M | 268,532 | 0.2% |
| Affimed N V | COM | N01045108 | $854.6K | 1,428,571 | 0.1% |
| Avalo Therapeutics Inc | COM NEW | 05338F207 | $444.0K | 1,250,000 | 0.1% |